BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16299802)

  • 21. Genetic analysis in soft-tissue tumors.
    Yunis JJ
    Lab Invest; 1994 Mar; 70(3):297-8. PubMed ID: 8145523
    [No Abstract]   [Full Text] [Related]  

  • 22. A gene expression signature associated with metastatic outcome in human leiomyosarcomas.
    Lee YF; John M; Falconer A; Edwards S; Clark J; Flohr P; Roe T; Wang R; Shipley J; Grimer RJ; Mangham DC; Thomas JM; Fisher C; Judson I; Cooper CS
    Cancer Res; 2004 Oct; 64(20):7201-4. PubMed ID: 15492233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ossifying synovial sarcoma.
    Hisaoka M; Matsuyama A; Shimajiri S; Akiba J; Kusano H; Hiraoka K; Shoda T; Hashimoto H
    Pathol Res Pract; 2009; 205(3):195-8. PubMed ID: 19041192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular aberrations.
    Verweij J; Baker LH
    Eur J Cancer; 2010 Mar; 46(5):863-8. PubMed ID: 20138507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in the genomics of soft tissue sarcomas.
    Conley AP; Trent J; Zhang W
    Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular genetics in the diagnosis of bone and soft tissue tumours].
    Bjerkehagen B; Myklebost O
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3286-9. PubMed ID: 16327856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA expression signature of human sarcomas.
    Subramanian S; Lui WO; Lee CH; Espinosa I; Nielsen TO; Heinrich MC; Corless CL; Fire AZ; van de Rijn M
    Oncogene; 2008 Mar; 27(14):2015-26. PubMed ID: 17922033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-expression profiling to classify soft-tissue sarcomas.
    Dirix LY; van Oosterom AT
    Lancet; 2002 Apr; 359(9314):1263-4. PubMed ID: 11965266
    [No Abstract]   [Full Text] [Related]  

  • 29. Sarcoma molecular testing: diagnosis and prognosis.
    Lazar AJ; Trent JC; Lev D
    Curr Oncol Rep; 2007 Jul; 9(4):309-15. PubMed ID: 17588356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunologic presentation of P53 protein in cell nucleus of soft tissue sarcoma].
    Budach V
    Strahlenther Onkol; 1995 Jan; 171(1):55-6. PubMed ID: 7839308
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of thermography in tumors of soft tissues].
    Gardani G; Bergonzi S; Viganotti G
    Radiol Med; 1984 Nov; 70(11):876-8. PubMed ID: 6100461
    [No Abstract]   [Full Text] [Related]  

  • 32. Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications.
    Marino-Enriquez A
    Surg Pathol Clin; 2015 Sep; 8(3):525-37. PubMed ID: 26297069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of sarcomas.
    Slavin JL; Thomas D
    Pathology; 2006 Apr; 38(2):101-2. PubMed ID: 16581648
    [No Abstract]   [Full Text] [Related]  

  • 34. A current perspective on the role for molecular studies in soft tissue tumor pathology.
    Dei Tos AP
    Semin Diagn Pathol; 2013 Nov; 30(4):375-81. PubMed ID: 24342291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
    Mariño-Enríquez A; Bovée JV
    Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chromosomal translocations in soft tissue sarcomas: from molecular biology to clinical application].
    Roma J; Masià A; Almazán-Moga A; Rebull M; Velasco P; Gallego S; Sánchez de Toledo J
    An Pediatr (Barc); 2012 Feb; 76(2):103.e1-7. PubMed ID: 22075174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences from tissue microarray in soft tissue sarcomas.
    Nilbert M; Engellau J
    Acta Orthop Scand Suppl; 2004 Apr; 75(311):29-34. PubMed ID: 15188663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiling of human synovial sarcoma cell line (Hs701.T) in response to IL-1beta stimulation.
    Ha WY; Li XJ; Yue PY; Wong DY; Yue KK; Chung WS; Zhao L; Leung PY; Liu L; Wong RN
    Inflamm Res; 2006 Jul; 55(7):293-9. PubMed ID: 16955392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of soft tissue sarcomas in 1118 cases.
    Fang ZW; Chen J; Teng S; Chen Y; Xue RF
    Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.